The EIF2AK2 gene helps cells sense viral infection and other stress, then temporarily slow protein production so the body can respond in a controlled way. This gene plays an important role in the early immune response and in protecting nerve cells from stress. If it does not work properly, cells may handle infection signals poorly, and rare harmful variants can be linked to developmental delay, speech differences, and involuntary muscle twisting or unusual postures (dystonia). EIF2AK2 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are sections of DNA that carry information your cells use to make molecules or regulate processes in the body. Some genes provide instructions for making proteins, the cell parts that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
EIF2AK2Gene function
What if the gene works
The EIF2AK2 gene helps cells respond to viral infection and other stress signals. Its protein slows new protein production when needed, which supports antiviral defense and helps cells keep growth and survival more balanced.
Risk
What if the gene does not work
Pathogenic variants in the EIF2AK2 gene are linked to a neurodevelopmental condition with developmental delay, speech difficulties, and dystonia or other movement problems; milder and more severe variants can influence when features begin and how marked they are.
Treatment
What does that mean for your treatment
No EIF2AK2-specific treatment or drug-selection approach is currently established in clinical guidelines. The EIF2AK2 gene is being studied as a drug target, and early-stage research is exploring PKR inhibitors and other stress-response modulators.
Conditions associated with EIF2AK2
Gene function
What if the gene works
Your cells use the EIF2AK2 gene to react quickly when they sense signs of a viral infection. Its main job is to briefly slow protein making and switch on defense signals. This helps the body mount a more organized antiviral response.
The EIF2AK2 gene helps cells detect double stranded RNA, a pattern often made during viral infection. This early sensing step helps the body begin an antiviral response.
When EIF2AK2 is switched on, it places a phosphate tag on eIF2α (a protein that starts protein making). This slows new protein production in a controlled way, which is central to how the EIF2AK2 gene helps control protein production during viral infection.
Active EIF2AK2 helps turn on interferon and other defense signals that alert cells to infection. These signals help coordinate a broader antiviral response across tissues.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
EIF2AK2 gene variants affect protein function mainly by making the protein switch on too easily or stay active too long, especially certain missense variants that change one amino acid. This can increase chemical tagging of eIF2α, a protein that helps control how much new protein a cell makes, and can overly slow protein production during stress. Some variants have a milder effect, while stronger activating variants can disrupt this stress response pathway more and may be linked to earlier or more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the EIF2AK2 gene cause a rare neurodevelopmental condition with developmental delay, speech or learning difficulties, and movement problems such as dystonia. In published studies, EIF2AK2 gene variants linked to dystonia and developmental delay have also been associated with seizures and changes seen on brain MRI in some people.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a clear diagnosis, particularly when several genes and environmental influences play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For EIF2AK2, risk is mainly tied to having a disease-causing gene change rather than to lifestyle or common environmental factors. In some people, illness, fever, or other body stress may trigger or worsen symptoms, but there is not enough evidence to say specific steps lower the underlying genetic risk.
Inheritance of EIF2AK2 variants
EIF2AK2-related conditions are inherited in an autosomal dominant pattern, which means one altered copy of the EIF2AK2 gene can be enough to cause the condition. If a parent carries the variant, each child has a 50% chance of inheriting it. In many reported families, the variant is new (de novo), meaning it arose in the child and was not inherited from either parent. For people searching how variants of the EIF2AK2 gene are inherited, this is the main well-established pattern.
What does my EIF2AK2 result mean for my family?
For the main condition linked to the EIF2AK2 gene, the pattern is usually dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change. In many families, though, the change starts new in the affected person, so a parent may not have it. Family testing can help clarify who else in the family may be affected or at risk of passing it on.
Genetic information
Genetic testing
How you find out about variants
EIF2AK2 genetic testing looks for variants in the EIF2AK2 gene using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA code and compares it with the usual sequence to see whether a variant is present. Results can show whether a change in this gene has been identified.
When should I consider getting a genetic test?
Genetic testing for the EIF2AK2 gene may be worth considering when someone has unexplained developmental delay, speech delay, changes in muscle tone, or unusual movement problems, especially if similar features run in the family. It can also help when a relative is known to carry an EIF2AK2 variant.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies by the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also affect how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Part of the difference is that genes can influence how the body breaks down, transports, or responds to a drug, which can affect both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes affect the way a person responds to medication. By studying patterns between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this subject in more detail, you can learn more in the LearnHub.
Drugs influenced by the EIF2AK2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, a new medicine, or changes in your health, talk with your doctor.
History
The EIF2AK2 gene emerged from interferon research in the late 1970s and 1980s, when scientists were trying to understand how cells respond to viral infection. Early work identified a protein first widely known as PKR, short for protein kinase R, before the gene itself was fully mapped and named. Initially understood only through visible traits, later recognized as tied to a specific gene, this pathway became an important part of molecular virology research. Through the 1990s, studies connected EIF2AK2 to broader cell stress responses as well as antiviral defense. Building on this early work, scientists uncovered more about the gene in inflammation and immune signaling. Today, EIF2AK2 is best known as one of the classic genes that helped shape modern understanding of how cells react to infection.